Mega Lifesciences PCL (BKK:MEGA)

Mega Lifesciences PCL Ratios and Metrics

Market cap in millions THB. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 29, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	27,028	28,990	35,093	40,760	44,029	31,169
Market Cap Growth	-17.33%	-17.39%	-13.90%	-7.43%	41.26%	37.50%
Enterprise Value	23,960	26,452	32,883	39,242	42,440	30,965
Last Close Price	31.00	31.56	36.72	41.08	42.80	29.57
PE Ratio	14.51	14.41	17.61	18.18	22.62	22.38
Forward PE	12.49	11.29	14.52	17.76	22.85	22.25
PS Ratio	1.89	1.88	2.23	2.59	3.11	2.47
PB Ratio	2.72	2.94	3.77	4.64	5.49	4.47
P/TBV Ratio	3.13	3.39	4.40	5.47	6.62	5.52
P/FCF Ratio	-	13.46	21.25	24.09	17.10	22.34
P/OCF Ratio	-	12.07	18.22	20.41	16.15	19.13
PEG Ratio	-	30.40	2.85	3.23	2.55	1.88
EV/Sales Ratio	1.67	1.72	2.09	2.50	3.00	2.46
EV/EBITDA Ratio	7.05	7.32	10.45	13.45	17.84	16.22
EV/EBIT Ratio	7.59	7.76	11.19	14.42	19.48	17.98
EV/FCF Ratio	21.07	12.28	19.91	23.19	16.48	22.20
Debt / Equity Ratio	0.06	0.05	0.03	0.05	0.04	0.09
Debt / EBITDA Ratio	0.19	0.13	0.08	0.14	0.15	0.33
Debt / FCF Ratio	0.56	0.23	0.15	0.25	0.14	0.46
Asset Turnover	0.98	1.09	1.09	1.13	1.14	1.14
Inventory Turnover	2.14	2.37	2.29	2.18	2.25	2.40
Quick Ratio	1.76	1.79	1.40	1.10	1.08	0.90
Current Ratio	2.57	2.61	2.26	1.91	1.92	1.79
Return on Equity (ROE)	18.87%	20.99%	22.04%	26.66%	25.87%	21.11%
Return on Assets (ROA)	13.48%	15.05%	12.77%	12.19%	10.97%	9.75%
Return on Capital (ROIC)	18.98%	21.40%	19.59%	19.35%	17.01%	14.65%
Return on Capital Employed (ROCE)	30.40%	33.10%	30.30%	29.90%	25.90%	23.50%
Earnings Yield	6.89%	6.94%	5.68%	5.50%	4.42%	4.47%
FCF Yield	4.21%	7.43%	4.71%	4.15%	5.85%	4.48%
Dividend Yield	5.20%	5.07%	4.36%	3.90%	3.23%	3.04%
Payout Ratio	74.86%	69.30%	72.23%	62.71%	47.41%	48.12%
Buyback Yield / Dilution	-	-	-	-	-	-0.12%
Total Shareholder Return	5.20%	5.07%	4.36%	3.90%	3.23%	2.93%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.